We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

23 hedge funds and large institutions have $129M invested in Nightstar Therapeutics plc American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

15% more funds holding

Funds holding: 2023 (+3)

9% more capital invested

Capital invested by funds: $118M → $129M (+$11.2M)

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
7
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NITE Hedge Fund Activity: Q2 2018 in Review

23 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q2 2018, worth a combined $129M — up 9.5% from $118M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NITE positions and 2 closed out — a net gain of 3 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Woodford Investment Management, opening a new position worth an estimated $4.48M. The largest seller was Wellington Management Group, cutting an estimated $3.65M.

  • 23 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q2 2018, up from 20 in Q1 2018.
  • Funds reported $129M of Nightstar Therapeutics plc American Depositary Shares stock for Q2 2018, up 9.5% quarter-over-quarter.
  • 5 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q2 2018 and 2 closed out, a net change of +3 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q2 2018 was Woodford Investment Management, an estimated $4.48M added.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q2 2018 was Wellington Management Group, an estimated $3.65M sold.

Based on aggregated 13F filings for Q2 2018.